MedPath

PHENAZOPYRIDINE HYDROCHLORIDE

PHENAZOPYRIDINE HYDROCHLORIDE

Approved
Approval ID

8ee8c0a7-ba7a-27b0-e053-2a95a90a186a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 21, 2020

Manufacturers
FDA

Direct_Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PHENAZOPYRIDINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-098
Product Classification
G
Generic Name
PHENAZOPYRIDINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 21, 2020
FDA Product Classification

INGREDIENTS (10)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
PHENAZOPYRIDINE HYDROCHLORIDEActive
Quantity: 200 mg in 1 1
Code: 0EWG668W17
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHENAZOPYRIDINE HYDROCHLORIDE - FDA Drug Approval Details